Indication-specific pricing may begin to reshape US reimbursement for anti-inflammatory drugs in the first half of 2017, when pharmacy benefit manager Express Scripts Holding Co. launches its new approach to contracting.
In a move away from paying for anti-inflammatory drugs as a broad category, Express Scripts will negotiate separate pricing for...







